Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 207.00M | £ 223.00M | £ 252.00M | £ 144.00M | £ 173.00M |
Total Assets | £ 4.95B | £ 5.19B | £ 5.21B | £ 5.06B | £ 5.11B |
Total Debt | £ 1.95B | £ 1.99B | £ 2.06B | £ 2.19B | £ 2.32B |
Net Debt | £ 1.74B | £ 1.77B | £ 1.81B | £ 2.04B | £ 2.15B |
Total Liabilities | £ 2.81B | £ 2.97B | £ 3.10B | £ 3.15B | £ 3.43B |
Stockholders Equity | £ 2.14B | £ 2.23B | £ 2.10B | £ 1.91B | £ 1.68B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |